New Section 232 tariffs impose up to 100% duties on patented drugs while offering relief tied to onshoring and MFN pricing commitments.
| less than a minute read
From Zero to 100% – New Section 232 Tariffs on Patented Drugs and the High-Stakes Onshoring and MFN Choices Ahead
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-10-05-17-16-21-912-6ac3db65936a86befc5df523.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-10-05-13-15-42-021-6ac3a2fe147a7b8e1aceede9.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-10-02-17-12-31-692-6abfe5ff7f63a687f5e4e75d.jpg)